The impact of such SRs for prostate cancer biology is currently not understood, but a reasonable hypothesis is that they develop – like the TMPRSS2:ERG gene fusion – as a consequence of highly active androgen receptor (AR) signaling. The gene discussed is ERG; the disease is prostate carcinoma.